on the issue of expected revenue per site per yr. simavita has stated it expects revenue of 15-70k per 100 bed site per yr. Is that direct revenue to simavita or does medline take a cut of that? The ceo seems to suggest the 15-70k is simavitas revenue range.
there are approx 27,000 100 bed sites in the usa. if they reach 10% of that market and achieve a revenue of 15k/site thats 40.5m.
with no current competitors, my confidence is growing. competitors will be inevitable if simavita start generating good returns. it will take them time to develop a superior product,get approval and enter the market. by that time sva will have a fair slice of the pie and the SP will have risen well beyond its current price.
it is also interesting to note that the recent sp decline follows the shape of the nasdaq.
looking forward to the first round of sales data from the us.
SVA Price at posting:
60.0¢ Sentiment: Buy Disclosure: Held
